Mitochondrial electron transport chain Coenzyme Q-binding sites (CoQ-binding sites)

Mitochondrial electron transport chain Coenzyme Q-binding sites are specialized pockets within respiratory complexes—primarily Complex I (NADH:ubiquinone oxidoreductase), Complex II (succinate dehydrogenase), and Complex III (ubiquinol:cytochrome c oxidoreductase)—that facilitate the transfer of electrons from various donors to ubiquinone (CoQ). These sites are critical for maintaining the proton motive force required for ATP synthesis and are major sources of reactive oxygen species (ROS) when electron flow is disrupted (Source: PubMed, PMID: 28434995). In disease states, mutations or environmental toxins affecting these sites can lead to mitochondrial dysfunction, contributing to neurodegenerative disorders like Parkinson's disease and rare metabolic encephalopathies (Source: UniProt, P03886). Pharmacologically, these sites are targeted by a variety of agents: Complex I Q-site inhibitors like rotenone are used as experimental tools, while atovaquone targets the Complex III Q-site to treat malaria and pneumocystis (Source: PubChem, CID 2274). Additionally, synthetic CoQ analogs like idebenone and MitoQ are designed to interact with these sites to bypass respiratory defects or act as targeted antioxidants (Source: NIH, StatPearls).

Other names

Ubiquinone-binding sitesQ-binding sitesMitochondrial respiratory chain Q-sitesCoenzyme Q10 binding sites

Inhibition of electron transfer by competitive or non-competitive binding to ubiquinone-binding pockets, modulation of reactive oxygen species (ROS) production, or restoration of electron flow in CoQ-deficient states.